Nilsine Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 1913043 GREENWOOD VILLAGE, CO

Position in LLY

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$13,292,084

+$3,105,632 QoQ

Shares Held

11,082

+0.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.30%

of 13F equity value

Holder Rank

#1,100

of 4,604 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nilsine Partners, LLC holds $35,772,221 across 11 Drug Manufacturers - General names. LLY ranks #1 (37.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	11,082	$13,292,084
2	JNJ	Johnson & Johnson	23,855	$6,058,454
3	MRK	Merck & Co., Inc.	26,144	$3,359,504
4	NVO	Novo Nordisk A S	69,503	$3,331,973
5	AMGN	Amgen Inc	9,193	$3,328,969
6	ABBV	AbbVie Inc.	10,103	$2,542,318
7	GILD	Gilead Sciences, Inc.	16,624	$2,100,276
8	NVS	Novartis AG	4,809	$753,666

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,292,084	11,082	+0.1%	Shares	Sole	2026-07-24
2026-03-31	$10,186,452	11,075	+8.6%	Shares	Sole	2026-04-29
2025-12-31	$10,955,288	10,194	+4.7%	Shares	Sole	2026-01-15
2025-09-30	$7,426,279	9,733	-19.9%	Shares	Sole	2025-10-06
2025-06-30	$9,473,628	12,153	-0.3%	Shares	Sole	2025-07-31
2025-03-31	$10,066,191	12,188	+2.3%	Shares	Sole	2025-04-22
2024-12-31	$9,199,152	11,916	+5.3%	Shares	Sole	2025-01-22
2024-09-30	$10,025,297	11,316	-0.7%	Shares	Sole	2024-10-30
2024-06-30	$10,315,899	11,394	+0.1%	Shares	Sole	2024-07-31
2024-03-31	$8,850,850	11,377	+7.7%	Shares	Sole	2024-04-22
2023-12-31	$6,158,549	10,565	+2.3%	Shares	Sole	2024-01-24
2023-09-30	$5,545,330	10,324	-1.4%	Shares	Sole	2023-11-01
2023-06-30	$4,908,344	10,466	0.0%	Shares	Sole	2023-07-21
2023-03-31	$3,594,233	10,466	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.